Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Depreciation and Depletion (2019 - 2025)

Historic Depreciation and Depletion for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to $92.6 million.

  • AdaptHealth's Depreciation and Depletion rose 868.54% to $92.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.0 million, marking a year-over-year increase of 263.84%. This contributed to the annual value of $343.1 million for FY2024, which is 202.74% down from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Depreciation and Depletion is $92.6 million, which was up 868.54% from $87.2 million recorded in Q2 2025.
  • AdaptHealth's 5-year Depreciation and Depletion high stood at $92.6 million for Q3 2025, and its period low was $36.9 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $85.2 million (2024), whereas its average is $78.2 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 20640.14% in 2021, then plummeted by 595.88% in 2023.
  • Quarter analysis of 5 years shows AdaptHealth's Depreciation and Depletion stood at $65.0 million in 2021, then surged by 42.0% to $92.3 million in 2022, then fell by 5.96% to $86.8 million in 2023, then fell by 2.07% to $85.0 million in 2024, then increased by 8.94% to $92.6 million in 2025.
  • Its last three reported values are $92.6 million in Q3 2025, $87.2 million for Q2 2025, and $89.2 million during Q1 2025.